158 related articles for article (PubMed ID: 19242462)
1. Alzheimer's disease: A prion protein connection.
Cisse M; Mucke L
Nature; 2009 Feb; 457(7233):1090-1. PubMed ID: 19242462
[No Abstract] [Full Text] [Related]
2. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers.
Laurén J; Gimbel DA; Nygaard HB; Gilbert JW; Strittmatter SM
Nature; 2009 Feb; 457(7233):1128-32. PubMed ID: 19242475
[TBL] [Abstract][Full Text] [Related]
3. A new take on prions: preventing Alzheimer's disease.
Hooper NM; Turner AJ
Trends Biochem Sci; 2008 Apr; 33(4):151-5. PubMed ID: 18343669
[TBL] [Abstract][Full Text] [Related]
4. Soluble prion protein and its N-terminal fragment prevent impairment of synaptic plasticity by Aβ oligomers: Implications for novel therapeutic strategy in Alzheimer's disease.
Scott-McKean JJ; Surewicz K; Choi JK; Ruffin VA; Salameh AI; Nieznanski K; Costa ACS; Surewicz WK
Neurobiol Dis; 2016 Jul; 91():124-131. PubMed ID: 26949218
[TBL] [Abstract][Full Text] [Related]
5. Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer's disease transgenic mice.
Kimura R; Devi L; Ohno M
J Neurochem; 2010 Apr; 113(1):248-61. PubMed ID: 20089133
[TBL] [Abstract][Full Text] [Related]
6. Involvement of the nitric oxide pathway in synaptic dysfunction following amyloid elevation in Alzheimer's disease.
Puzzo D; Palmeri A; Arancio O
Rev Neurosci; 2006; 17(5):497-523. PubMed ID: 17180876
[TBL] [Abstract][Full Text] [Related]
7. Activation of β
Chai GS; Wang YY; Zhu D; Yasheng A; Zhao P
Neurosci Lett; 2017 Jan; 636():158-164. PubMed ID: 27838449
[TBL] [Abstract][Full Text] [Related]
8. Prion protein in Alzheimer's pathogenesis: a hot and controversial issue.
Benilova I; De Strooper B
EMBO Mol Med; 2010 Aug; 2(8):289-90. PubMed ID: 20698011
[TBL] [Abstract][Full Text] [Related]
9. Extracellular Forms of Aβ and Tau from iPSC Models of Alzheimer's Disease Disrupt Synaptic Plasticity.
Hu NW; Corbett GT; Moore S; Klyubin I; O'Malley TT; Walsh DM; Livesey FJ; Rowan MJ
Cell Rep; 2018 May; 23(7):1932-1938. PubMed ID: 29768194
[TBL] [Abstract][Full Text] [Related]
10. Synaptic activity reduces intraneuronal Abeta, promotes APP transport to synapses, and protects against Abeta-related synaptic alterations.
Tampellini D; Rahman N; Gallo EF; Huang Z; Dumont M; Capetillo-Zarate E; Ma T; Zheng R; Lu B; Nanus DM; Lin MT; Gouras GK
J Neurosci; 2009 Aug; 29(31):9704-13. PubMed ID: 19657023
[TBL] [Abstract][Full Text] [Related]
11. Impairment in hippocampal long-term potentiation in mice under-expressing the Alzheimer's disease related gene presenilin-1.
Morton RA; Kuenzi FM; Fitzjohn SM; Rosahl TW; Smith D; Zheng H; Shearman M; Collingridge GL; Seabrook GR
Neurosci Lett; 2002 Feb; 319(1):37-40. PubMed ID: 11814648
[TBL] [Abstract][Full Text] [Related]
12. Prion protein and Abeta-related synaptic toxicity impairment.
Calella AM; Farinelli M; Nuvolone M; Mirante O; Moos R; Falsig J; Mansuy IM; Aguzzi A
EMBO Mol Med; 2010 Aug; 2(8):306-14. PubMed ID: 20665634
[TBL] [Abstract][Full Text] [Related]
13. Prions, prionoids and pathogenic proteins in Alzheimer disease.
Ashe KH; Aguzzi A
Prion; 2013; 7(1):55-9. PubMed ID: 23208281
[TBL] [Abstract][Full Text] [Related]
14. High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer's disease.
Dohler F; Sepulveda-Falla D; Krasemann S; Altmeppen H; Schlüter H; Hildebrand D; Zerr I; Matschke J; Glatzel M
Brain; 2014 Mar; 137(Pt 3):873-86. PubMed ID: 24519981
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's disease: Recollection of lost memories.
Malenka RC; Malinow R
Nature; 2011 Jan; 469(7328):44-5. PubMed ID: 21209657
[TBL] [Abstract][Full Text] [Related]
16. Probiotic treatment improves the impaired spatial cognitive performance and restores synaptic plasticity in an animal model of Alzheimer's disease.
Rezaei Asl Z; Sepehri G; Salami M
Behav Brain Res; 2019 Dec; 376():112183. PubMed ID: 31472194
[TBL] [Abstract][Full Text] [Related]
17. Distinct prion-like strains of amyloid beta implicated in phenotypic diversity of Alzheimer's disease.
Cohen M; Appleby B; Safar JG
Prion; 2016; 10(1):9-17. PubMed ID: 26809345
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease.
Querfurth HW; LaFerla FM
N Engl J Med; 2010 Jan; 362(4):329-44. PubMed ID: 20107219
[No Abstract] [Full Text] [Related]
19. Early-onset familial Alzheimer disease with coexisting beta-amyloid and prion pathology.
Leuba G; Saini K; Savioz A; Charnay Y
JAMA; 2000 Apr; 283(13):1689-91. PubMed ID: 10755493
[No Abstract] [Full Text] [Related]
20. Ablating ErbB4 in PV neurons attenuates synaptic and cognitive deficits in an animal model of Alzheimer's disease.
Zhang H; Zhang L; Zhou D; He X; Wang D; Pan H; Zhang X; Mei Y; Qian Q; Zheng T; Jones FE; Sun B
Neurobiol Dis; 2017 Oct; 106():171-180. PubMed ID: 28684271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
